Short answer
ANI PHARMACEUTICALS INC (ANIP) filed an 8-K current report with the SEC on April 7, 2026 reporting Item 4.01 (Changes in Registrant's Certifying Accountant). EY appointed as ANI Pharmaceuticals’ independent registered public accounting firm effective April 1, 2026.
- This filing includes Item 4.01, an item that often signal trouble.
ANI PHARMACEUTICALS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 4.01 · Changes in Registrant's Certifying Accountant
- EY appointed as ANI Pharmaceuticals’ independent registered public accounting firm effective April 1, 2026
- Appointment covers fiscal year ending December 31, 2026
- No prior consultations with EY on reportable accounting matters during fiscal years 2025, 2024, or interim period through April 1, 2026
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other ANI PHARMACEUTICALS INC 8-K filings
Get the next ANIP 8-K as it lands
Follow ANIP for push alerts, or ask the research agent what this filing means.